PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsendometrial neoplasms
MeSH D016889 - endometrial neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014594:Uterine neoplasms
26 Companies
4 Drugs
$
Success rate
D016889: 
Endometrial neoplasms
52 Companies
10 Drugs
$
Success rate
D018269:Endometrioid carcinoma
0 Companies
0 Drugs
Success rate
D036821:Endometrial stromal tumors
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarboplatin Carboplatin  2005-09-21   
Medroxyprogesterone Medroxyprogesterone  2004-10-27   
Megestrol Megestrol  1998-02-27   
Cyclophosphamide Neosar  1993-04-29   
Novast LaboratoriesCarboplatin Carboplatin  2017-04-26   
IngenusCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
MylanCarboplatin Carboplatin  2007-04-24   
Medroxyprogesterone Medroxyprogesterone  2018-10-12   
NATCO PharmaCarboplatin Carboplatin  2012-05-29   
Johnson & JohnsonLeuprolide Viadur  2000-03-03   
GSKDostarlimab Jemperli  2021-04-21   
CiplaCarboplatin Carboplatin  2006-01-27   
Cyclophosphamide Cyclophosphamide  2019-01-18   
Medroxyprogesterone Medroxyprogesterone  2019-01-25   
SandozCarboplatin Carboplatin  2005-03-18   
Leuprolide Leuprolide  1998-08-04   
Medroxyprogesterone Medroxyprogesterone  2009-05-20   
Cyclophosphamide Cyclophosphamide  2023-09-12   
AbbVieLeuprolide, Norethindrone Lupaneta Pack  2012-12-14   
Leuprolide Lupron  1985-04-09 $783 M Y2021 
Leuprolide Lupron Depot  1989-01-26   
Leuprolide Lupron Depot-ped 2028-03-22 1993-04-16   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
71%
77/108
Phase 2
24%
36/151
Phase 3
26%
14/53
Approved: 7Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Carboplatin,
Cyclophosphamide,
Medroxyprogesterone,
Medroxyprogesterone acetate
Mylan
Carboplatin
Johnson & Johnson
Leuprolide
GSK
Dostarlimab,
Antithrombin iii
AbbVie
Leuprolide,
Norethindrone
Sanofi
Leuprolide,
Transplatin,
PILARALISIB,
SERIBANTUMAB
Merck Sharp & Dohme
Pembrolizumab,
Transplatin,
Chlormadinone acetate,
Epacadostat,
Ridaforolimus,
MIRANSERTIB,
SECLIDEMSTAT,
TEMUTERKIB,
Vibostolimab,
Nc410,
Np137
Pfizer
Medroxyprogesterone,
Medroxyprogesterone acetate,
Ado-trastuzumab emtansine,
Giredestrant,
Tiragolumab,
Ipatasertib,
Inavolisib,
Sasanlimab,
Terfenadine,
Gedatolisib
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use